Australia's first psychedelic laboratory is pioneering a rigorous program of research and training in psychedelic therapies. Led by Dr Paul Liknaitzky, the lab is focused on investigating novel applications for psychedelic therapies, translating evidence into best clinical practice, exploring and mitigating under-examined risks, delivering next-generation therapist training, and improving access and affordability.
The Clinical Psychedelic Lab is part of the Department of Psychiatry within the School of Clinical Sciences.